196 related articles for article (PubMed ID: 6938964)
1. Covalent binding and hemolytic activity of complement proteins.
Law SK; Lichtenberg NA; Levine RP
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
[TBL] [Abstract][Full Text] [Related]
2. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
Pangburn MK; Müller-Eberhard HJ
J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
[TBL] [Abstract][Full Text] [Related]
3. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
Andersson M; Hanson A; Englund G; Dahlbäck B
Eur J Clin Pharmacol; 1991; 40(3):261-5. PubMed ID: 2060562
[TBL] [Abstract][Full Text] [Related]
5. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
[TBL] [Abstract][Full Text] [Related]
6. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
7. Covalent modification of fourth component of human complement with primary amines. Binding studies with metastable fragment C4b and with C4.
Gorski JP; Silversmith R; Fiebeger S; Moilanen T
J Biol Chem; 1982 Sep; 257(18):10948-54. PubMed ID: 6980883
[TBL] [Abstract][Full Text] [Related]
8. Cyanate as an inactivator of complement proteins.
Schultz DR; Arnold PI
J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
Sahu A; Rawal N; Pangburn MK
Biochem Pharmacol; 1999 Jun; 57(12):1439-46. PubMed ID: 10353266
[TBL] [Abstract][Full Text] [Related]
10. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
11. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity.
Mannes M; Dopler A; Zolk O; Lang SJ; Halbgebauer R; Höchsmann B; Skerra A; Braun CK; Huber-Lang M; Schrezenmeier H; Schmidt CQ
Blood; 2021 Jan; 137(4):443-455. PubMed ID: 33507296
[TBL] [Abstract][Full Text] [Related]
12. Binding and activation of C4 and C3 on the red cell surface by non-complement enzymes.
Kirschfink M; Borsos T
Mol Immunol; 1988 May; 25(5):505-12. PubMed ID: 3412332
[TBL] [Abstract][Full Text] [Related]
13. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
Hostetter MK; Krueger RA; Schmeling DJ
J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
[TBL] [Abstract][Full Text] [Related]
14. The internal thioester and the covalent binding properties of the complement proteins C3 and C4.
Law SK; Dodds AW
Protein Sci; 1997 Feb; 6(2):263-74. PubMed ID: 9041627
[TBL] [Abstract][Full Text] [Related]
15. Evidence for presence of an internal thiolester bond in third component of human complement.
Tack BF; Harrison RA; Janatova J; Thomas ML; Prahl JW
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5764-8. PubMed ID: 6934510
[TBL] [Abstract][Full Text] [Related]
16. The covalent binding story of the complement proteins C3 and C4 (I) 1972-1981.
Law SKA; Levine RP
Immunobiology; 2019 Nov; 224(6):827-833. PubMed ID: 31445811
[TBL] [Abstract][Full Text] [Related]
17. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.
Janatova J; Lorenz PE; Schechter AN; Prahl JW; Tack BF
Biochemistry; 1980 Sep; 19(19):4471-8. PubMed ID: 7407085
[TBL] [Abstract][Full Text] [Related]
18. The covalent-binding reaction of complement component C3.
Sim RB; Twose TM; Paterson DS; Sim E
Biochem J; 1981 Jan; 193(1):115-27. PubMed ID: 7305916
[TBL] [Abstract][Full Text] [Related]
19. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
Isenman DE; Kells DI; Cooper NR; Müller-Eberhard HJ; Pangburn MK
Biochemistry; 1981 Jul; 20(15):4458-67. PubMed ID: 7284336
[TBL] [Abstract][Full Text] [Related]
20. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
